Results 141 to 150 of about 61,779 (245)

Risk of Donor‐Derived Infections From Organ Donors Colonized or Infected With Multidrug‐Resistant Gram‐Negative Bacteria: A Systematic Review and Meta‐Analysis

Clinical Transplantation, Volume 40, Issue 10, October 2026.
ABSTRACT Background The presence of multidrug‐resistant Gram‐negative (MDR‐GN) organisms in solid organ transplantation (SOT) donors raises concerns regarding transplant safety. Methods We searched PubMed and Scopus (2010–2025) for observational studies reporting donor‐derived infections (DDI) among SOT recipients from donors with MDR‐GN colonization ...
Themistoklis Paraskevas, Christodoulos Chatzigrigoriadis, Ioannis D. Kostakis, Nikolaos Karydis, Marios Papasotiriou, Theodoros Ntrinias, Ioannis Maroulis, Markos Marangos, Evangelos Papachristou, Paolo Antonio Grossi, Stelios F. Assimakopoulos   +10 more
wiley   +1 more source

Real‐World Claims Data on Prescribed Drugs and the Associated Drug–Drug Interaction Risk in Sickle Cell Disease in the United States

Clinical and Translational Science, Volume 19, Issue 10, October 2026.
Real‐world prescription data from 6230 adolescents and adults living with sickle cell disease (SCD) were combined with a drug–drug interaction (DDI) database to characterize the population‐level DDI risk. The findings support a DDI risk assessment for development of novel SCD therapies and during clinical management of SCD.ABSTRACTSickle cell disease ...
Rune Aabjerg Nørgaard, Laura Grenier, Peter Bruun‐Rasmussen, Ifeyinwa Osunkwo, Carolina Säll   +4 more
wiley   +1 more source

From Real World Data to Real Impact: A Co‐Medication Framework for Lung Cancer to Advance DDI Assessment and Patient‐Centric Drug Development

Clinical and Translational Science, Volume 19, Issue 10, October 2026.
ABSTRACT Lung cancer predominantly affects older adults who already experience comorbidities and are at increased risk of drug–drug interactions (DDIs) due to polypharmacy. Traditional DDI assessments often do not fully capture complex co‐medication patterns observed in real‐world practice due to the risk of introducing confounding factors.
Mareena Biju, HeeJae Choi, Shilpa Madari, Annie Carlisle, Ashish Sharma, Christina Kunz, Fenglei Huang   +6 more
wiley   +1 more source

S1‐Leitlinie Tinea capitis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 10, Page 1510-1524, October 2026.
Zusammenfassung Die unter Federführung der Deutschen Dermatologischen Gesellschaft e. V. (DDG) erstellte S1‐Leitlinie soll Ärzten eine strukturierte Entscheidungsgrundlage für die Versorgung von Patienten mit Tinea capitis bieten und zur Verbesserung der Diagnosesicherheit, Therapieadhärenz und Prävention beitragen.
Peter Mayser, Dietrich Abeck, Philipp P. Bosshard, Jochen Brasch, Georg Daeschlein, Isaak Effendy, Yvonne Gräser, Peter Höger, Julia Huynh, Maria Kinberger, Annette Kolb‐Mäurer, Katharina Antonia Langen, Bartosz Malisiewicz, Alexander Nast, Hagen Ott, Christin Pelzer, Dieter Reinel, Martin Schaller, Silke Uhrlaß, Pietro Nenoff   +19 more
wiley   +1 more source

Mechanisms of fluconazole resistance in Candida parapsilosis clinical isolates

, 2013
Candida parapsilosis is an emerging fungal pathogen and a leading cause of hospital-acquired bloodstream fungal infections. The prophylactic and long-term use of fluconazole, a widely used antifungal, has resulted in an increased prevalence of resistance
Wanamaker, Eileen B.
core  

Consensus‐based Guideline on tinea capitis

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 10, Page e1510-e1522, October 2026.
Summary The consensus‐based guideline developed under the auspices of the German Dermatological Society (DDG) is intended to provide physicians with a structured framework for clinical decision‐making in the management of patients with tinea capitis and to contribute to improved diagnostic accuracy, treatment adherence, and prevention. Tinea capitis is
Peter Mayser, Dietrich Abeck, Philipp P. Bosshard, Jochen Brasch, Georg Daeschlein, Isaak Effendy, Yvonne Gräser, Peter Höger, Julia Huynh, Maria Kinberger, Annette Kolb‐Mäurer, Katharina Antonia Langen, Bartosz Malisiewicz, Alexander Nast, Hagen Ott, Christin Pelzer, Dieter Reinel, Martin Schaller, Silke Uhrlaß, Pietro Nenoff   +19 more
wiley   +1 more source

Deep and disseminated dermatophytosis in immunocompromised populations—A systematic review

Journal of the European Academy of Dermatology and Venereology, Volume 40, Issue 10, Page 1648-1661, October 2026.
Dermatophyte infections of the dermis and subcutaneous tissue (i.e. deep dermatophytosis)—associated with secondary complications including pseudomycetoma and systemic dissemination—affect vulnerable populations with primary or acquired immunodeficiencies.
Aditya K. Gupta, Tong Wang, Susmita, Ditte Marie L. Saunte, Roderick Hay, Vincent Piguet   +5 more
wiley   +1 more source

Unmasking Primary Candidemia: Clinical Features and Implications for Management

Mycoses, Volume 69, Issue 10, October 2026.
ABSTRACT Background Source identification in candidemia is crucial for management and prognosis; however, a substantial proportion of cases are classified as primary candidemia without an identifiable source. Objectives To assess the clinical relevance of primary candidemia and its impact on 7‐day and 30‐day mortality: Methods Single‐center ...
Marta Albanell‐Fernández, Andrea Vergara, Marta Bodro, Josep Mensa, Montse Tuset, Sabina Herrera, Álex Soriano   +6 more
wiley   +1 more source

From Plants to Animals: Cross‐Kingdom Infection by Fungal Phytopathogens

Mycoses, Volume 69, Issue 10, October 2026.
ABSTRACT Plant pathogenic fungi exhibit significant ecological diversity that is under pressure from climate change, yet their relevance to both human and ecosystem health remains underexplored within the One Health framework. Several phytopathogenic lineages have demonstrated the ability to infect vertebrate hosts.
Aditya K. Gupta, Tong Wang, Ditte Marie L. Saunte, Sybren de Hoog   +3 more
wiley   +1 more source

Simultaneous quantification of venetoclax, selinexor, voriconazole and fluconazole in human plasma by HPLC-MS/MS and its application in hematological malignancies. [PDF]

Front Pharmacol
Han F, Wang Y, Jian Y, Hu T, Zhu Y, Ding X, Zhang J, Wei R, Zhu H, An Z.   +9 more
europepmc   +1 more source